LY3876602

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3876602, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants [Phase 1]